Skip to main content
background gradient

Volume 9Issue 12

Special Report

Free Access
No protocol and no liability: a call for COVID crisis guidelines that protect vulnerable populations
  • Chiara Caraccio,
  • Robert S White, and
  • Rohan Jotwani
pp829–837
Published Online:24 July 2020
Preview Abstract

Meta-Analysis

Free Access
Impact of chronic obstructive pulmonary disease on mortality in community acquired pneumonia: a meta-analysis
  • Hui Ma,
  • Ting Liu,
  • Yongxiang Zhang,
  • Zhen Ye,
  • Wei Jia, and
  • Yuechuan Li
pp839–848
Published Online:4 September 2020
Preview Abstract

Research Article

Open Access
Tisagenlecleucel versus historical standard therapies for pediatric relapsed/refractory acute lymphoblastic leukemia
  • Qiufei Ma,
  • Jie Zhang,
  • Elliott O'Brien,
  • Amber L Martin, and
  • Andrea Chassot Agostinho
pp849–860
Published Online:30 June 2020
Preview Abstract
Open Access
Matching-adjusted indirect comparison: entrectinib versus crizotinib in ROS1 fusion-positive non-small cell lung cancer
  • Paula Chu,
  • Miranta Antoniou,
  • Mohit K Bhutani,
  • Amine Aziez, and
  • Monica Daigl
pp861–876
Published Online:10 July 2020
Preview Abstract
Free Access
Using the primary site as a prognostic tool for nodal mantle cell lymphoma: a SEER-based study
  • Mohamed Gomaa Kamel,
  • Amr Ehab El-Qushayri,
  • Ahmed Kamal Sayed, and
  • Nguyen Tien Huy
pp861–876
Published Online:4 September 2020
Preview Abstract
Open Access
Golimumab improves patient-reported outcomes in daily practice of inflammatory rheumatic diseases in Germany
  • Klaus Krueger,
  • Sven Remstedt,
  • Astrid Thiele, and
  • Susanne Hohenberger
pp891–902
Published Online:29 July 2020
Preview Abstract